Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028

Published Date : 31-Oct-2022

Pages: 122

Formats: PDF

The Latin America, Middle East and Africa Large Molecule Bioanalytical Testing Services Market would witness market growth of 12.5% CAGR during the forecast period (2022-2028).

Due to its target specificity, decreased toxicity, and increased potency, large-molecule therapies have become more popular recently. As a result, numerous pharmaceutical companies now provide a wide range of large-molecule medications. The usage of LC-MS has increased along with the utilization of large-molecule medicines. Although LBAs remain the industry standard for large-molecule quantification, LC-MS provides various advantages, including multiplexing and a wider linear dynamic range. The use of LC-MS for these chemicals still faces a number of difficulties, though.

The market for large molecule bioanalytical testing services is anticipated to rise as a result of the increasing complexity of product engineering & designs and the rising need for sophisticated and top-notch testing services. Pharmaceutical companies are under increased pressure to adopt new technologies into their services to meet consumer demand as a result of the swift improvements in healthcare. Due to faster time to market, increased regulatory scrutiny, and a higher risk of product failure, there is an increasing demand for large molecule bioanalytical testing services.

In recent years, Abu Dhabi and Dubai have both made efforts to promote medical innovation and ensure that their citizens have access to medical treatment of the highest possible standard. The Health Authority in Abu Dhabi is working to improve the quality of care, expand access to services, transition from public to private providers in a safe and efficient manner, and implement a latest financing model through an innovative system of mandatory health insurance. The rising investment in the healthcare sector of UAE would support the market growth in the region.

The Brazil market dominated the LAMEA Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $45.4 million by 2028. The Argentina market is showcasing a CAGR of 13.1% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 12.2% during (2022 - 2028).

Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Large Molecule Bioanalytical Testing Services Market is Predict to reach $2.8 Billion by 2028, at a CAGR of 9.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-user

  • SMEs
  • Large Firms

By Test Type

  • Bioavailability
  • ADME
  • PD
  • Bioequivalence
  • Others

By Type

  • ADA
  • Pharmacokinetics
  • Others

By Phase

  • Clinical
  • Pre-clinical
    • With Antibody
    • Without Antibody (ELISA Based Assay)

By Therapeutic Areas

  • Oncology
  • Neurology
  • Infectious Diseases
  • Cardiology
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Laboratory Corporation Of America Holdings
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
  • SGS S.A.
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • ICON Plc
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Large Molecule Bioanalytical Testing Services Market, by End-user
1.4.2 LAMEA Large Molecule Bioanalytical Testing Services Market, by Test Type
1.4.3 LAMEA Large Molecule Bioanalytical Testing Services Market, by Type
1.4.4 LAMEA Large Molecule Bioanalytical Testing Services Market, by Phase
1.4.5 LAMEA Large Molecule Bioanalytical Testing Services Market, by Therapeutic Areas
1.4.6 LAMEA Large Molecule Bioanalytical Testing Services Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Large Molecule Bioanalytical Testing Services Market

Chapter 4. LAMEA Large Molecule Bioanalytical Testing Services Market by End-user
4.1 LAMEA SMEs Market by Country
4.2 LAMEA Large Firms Market by Country

Chapter 5. LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type
5.1 LAMEA Bioavailability Market by Country
5.2 LAMEA ADME Market by Country
5.3 LAMEA PD Market by Country
5.4 LAMEA Bioequivalence Market by Country
5.5 LAMEA Others Market by Country

Chapter 6. LAMEA Large Molecule Bioanalytical Testing Services Market by Type
6.1 LAMEA ADA Market by Country
6.2 LAMEA Pharmacokinetics Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Large Molecule Bioanalytical Testing Services Market by Phase
7.1 LAMEA Clinical Market by Country
7.2 LAMEA Pre-clinical Market by Country
7.3 LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
7.3.1 LAMEA With Antibody Market by Country
7.3.2 LAMEA Without Antibody (ELISA Based Assay) Market by Country

Chapter 8. LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
8.1 LAMEA Oncology Market by Country
8.2 LAMEA Neurology Market by Country
8.3 LAMEA Infectious Diseases Market by Country
8.4 LAMEA Cardiology Market by Country
8.5 LAMEA Others Market by Country

Chapter 9. LAMEA Large Molecule Bioanalytical Testing Services Market by Country
9.1 Brazil Large Molecule Bioanalytical Testing Services Market
9.1.1 Brazil Large Molecule Bioanalytical Testing Services Market by End-user
9.1.2 Brazil Large Molecule Bioanalytical Testing Services Market by Test Type
9.1.3 Brazil Large Molecule Bioanalytical Testing Services Market by Type
9.1.4 Brazil Large Molecule Bioanalytical Testing Services Market by Phase
9.1.4.1 Brazil Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.1.5 Brazil Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.2 Argentina Large Molecule Bioanalytical Testing Services Market
9.2.1 Argentina Large Molecule Bioanalytical Testing Services Market by End-user
9.2.2 Argentina Large Molecule Bioanalytical Testing Services Market by Test Type
9.2.3 Argentina Large Molecule Bioanalytical Testing Services Market by Type
9.2.4 Argentina Large Molecule Bioanalytical Testing Services Market by Phase
9.2.4.1 Argentina Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.2.5 Argentina Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.3 UAE Large Molecule Bioanalytical Testing Services Market
9.3.1 UAE Large Molecule Bioanalytical Testing Services Market by End-user
9.3.2 UAE Large Molecule Bioanalytical Testing Services Market by Test Type
9.3.3 UAE Large Molecule Bioanalytical Testing Services Market by Type
9.3.4 UAE Large Molecule Bioanalytical Testing Services Market by Phase
9.3.4.1 UAE Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.3.5 UAE Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.4 Saudi Arabia Large Molecule Bioanalytical Testing Services Market
9.4.1 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by End-user
9.4.2 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Test Type
9.4.3 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Type
9.4.4 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Phase
9.4.4.1 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.4.5 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.5 South Africa Large Molecule Bioanalytical Testing Services Market
9.5.1 South Africa Large Molecule Bioanalytical Testing Services Market by End-user
9.5.2 South Africa Large Molecule Bioanalytical Testing Services Market by Test Type
9.5.3 South Africa Large Molecule Bioanalytical Testing Services Market by Type
9.5.4 South Africa Large Molecule Bioanalytical Testing Services Market by Phase
9.5.4.1 South Africa Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.5.5 South Africa Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.6 Nigeria Large Molecule Bioanalytical Testing Services Market
9.6.1 Nigeria Large Molecule Bioanalytical Testing Services Market by End-user
9.6.2 Nigeria Large Molecule Bioanalytical Testing Services Market by Test Type
9.6.3 Nigeria Large Molecule Bioanalytical Testing Services Market by Type
9.6.4 Nigeria Large Molecule Bioanalytical Testing Services Market by Phase
9.6.4.1 Nigeria Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.6.5 Nigeria Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.7 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market
9.7.1 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by End-user
9.7.2 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type
9.7.3 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Type
9.7.4 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Phase
9.7.4.1 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.7.5 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas

Chapter 10. Company Profiles
10.1 IQVIA Holdings, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Product Launches and Product Expansions:
10.1.4.2 Geographical Expansions:
10.2 SGS S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Geographical Expansions:
10.3 Intertek Group PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.4 ICON plc
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Charles River Laboratories International, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Acquisition and Mergers:
10.6 Thermo Fisher Scientific, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Syneos Health, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.8 Laboratory Corporation Of America Holdings
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Geographical Expansions:
10.9 Pace Analytical Services, LLC
10.9.1 Company Overview
TABLE 1 LAMEA Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 4 LAMEA Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 5 LAMEA SMEs Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA SMEs Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Large Firms Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Large Firms Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 10 LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 11 LAMEA Bioavailability Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Bioavailability Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA ADME Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA ADME Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA PD Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA PD Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Bioequivalence Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Bioequivalence Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 22 LAMEA Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 23 LAMEA ADA Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA ADA Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Pharmacokinetics Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Pharmacokinetics Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 30 LAMEA Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 31 LAMEA Clinical Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Clinical Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Pre-clinical Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Pre-clinical Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 36 LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 37 LAMEA With Antibody Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA With Antibody Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Without Antibody (ELISA Based Assay) Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Without Antibody (ELISA Based Assay) Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 42 LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 43 LAMEA Oncology Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Oncology Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Neurology Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Neurology Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 49 LAMEA Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 51 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 52 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 53 LAMEA Large Molecule Bioanalytical Testing Services Market by Country, 2018 - 2021, USD Million
TABLE 54 LAMEA Large Molecule Bioanalytical Testing Services Market by Country, 2022 - 2028, USD Million
TABLE 55 Brazil Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 56 Brazil Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 57 Brazil Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 58 Brazil Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 59 Brazil Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 60 Brazil Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 61 Brazil Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 62 Brazil Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 63 Brazil Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 64 Brazil Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 65 Brazil Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 66 Brazil Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 67 Brazil Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 68 Brazil Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 69 Argentina Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 70 Argentina Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 71 Argentina Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 72 Argentina Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 73 Argentina Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 74 Argentina Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 75 Argentina Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 76 Argentina Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 77 Argentina Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 78 Argentina Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 79 Argentina Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 80 Argentina Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 81 Argentina Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 82 Argentina Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 83 UAE Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 84 UAE Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 85 UAE Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 86 UAE Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 87 UAE Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 88 UAE Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 89 UAE Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 90 UAE Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 91 UAE Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 92 UAE Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 93 UAE Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 94 UAE Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 95 UAE Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 96 UAE Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 97 Saudi Arabia Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 98 Saudi Arabia Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 99 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 100 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 101 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 102 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 103 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 104 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 105 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 106 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 107 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 108 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 109 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 110 Saudi Arabia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 111 South Africa Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 112 South Africa Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 113 South Africa Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 114 South Africa Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 115 South Africa Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 116 South Africa Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 117 South Africa Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 118 South Africa Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 119 South Africa Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 120 South Africa Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 121 South Africa Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 122 South Africa Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 123 South Africa Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 124 South Africa Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 125 Nigeria Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 126 Nigeria Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 127 Nigeria Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 128 Nigeria Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 129 Nigeria Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 130 Nigeria Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 131 Nigeria Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 132 Nigeria Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 133 Nigeria Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 134 Nigeria Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 135 Nigeria Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 136 Nigeria Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 137 Nigeria Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 138 Nigeria Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 139 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 140 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 141 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 142 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 143 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 144 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 145 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 146 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 147 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 148 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 149 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 150 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 151 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 152 Rest of LAMEA Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 153 Key information – IQVIA Holdings, Inc.
TABLE 154 Key Information – SGS S.A.
TABLE 155 Key Information – Intertek Group PLC
TABLE 156 Key Information – ICON PLC
TABLE 157 key information – Charles River Laboratories International, Inc.
TABLE 158 Key Information – Thermo Fisher Scientific, Inc.
TABLE 159 Key Information – Syneos Health, Inc.
TABLE 160 Key Information – Laboratory Corporation Of America Holdings
TABLE 161 Key Information – Pace Analytical Services, LLC

List of Figures
FIG 1 Methodology for the research

Purchase Full Report of
LAMEA Large Molecule Bioanalytical Testing Services Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL